Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

S Tomlanovich

Showing results (11-20 of 26) with videos related to

Pageof 3
Sort By:
Pharmacotherapy|May 1, 1997
Pharmacokinetics of mycophenolate mofetil and intravenous ganciclovir alone and in combination in renal transplant recipientsE J Wolfe, V Mathur, S Tomlanovich, et al.
Transplantation Proceedings|January 1, 1998
Selection strategies for successful utilization of less than 15.kg pediatric donor kidneysP N Bretan, C Freise, R Goldstein, et al.
Kidney International|May 20, 2003
Health-related fitness and quality of life following steroid withdrawal in renal transplant recipientsPatricia L Painter, K S Topp, J B Krasnoff, et al.
Transplantation Proceedings|February 1, 1991
Improved results with combined donor-specific transfusion (DST) and sequential therapy protocolO Salvatierra, J McVicar, J Melzer, et al.
Transplantation Proceedings|February 1, 1987
Observations relating to the incidence of the acquired immune deficiency syndrome and other possibly associated conditions in a large population of renal transplant recipientsN J Feduska, H A Perkins, J Melzer, et al.
Transplantation|January 27, 1997
Immunologic and patient selection strategies for successful utilization of less than 15 kg pediatric donor kidneys--long term experiences with 40 transplantsP N Bretan, C Friese, R B Goldstein, et al.
Clinical Nephrology|August 31, 2006
Long-term administration of enteric-coated mycophenolate sodium (EC-MPS; myfortic) is safe in kidney transplant patientsM Salvadori, H Holzer, G Civati, et al.
Transplantation Proceedings|February 1, 1987
Donor-specific blood transfusions versus cyclosporine--the DST storyO Salvatierra, J Melzer, F Vincenti, et al.
Transplantation|May 27, 1994
Determination of blood flow to the transplanted kidney. A novel application of phase-contrast, cine magnetic resonance imagingB D Myers, F G Sommer, K Li, et al.
Transplantation|January 11, 2000
Prednisone withdrawal in kidney transplant recipients on cyclosporine and mycophenolate mofetil--a prospective randomized study. Steroid Withdrawal Study GroupN Ahsan, D Hricik, A Matas, et al.
Pageof 3

Showing results (11-20 of 26) with videos related to

Sort By:
Pageof 3
Pharmacotherapy|May 1, 1997
Pharmacokinetics of mycophenolate mofetil and intravenous ganciclovir alone and in combination in renal transplant recipientsE J Wolfe, V Mathur, S Tomlanovich, et al.
Transplantation Proceedings|January 1, 1998
Selection strategies for successful utilization of less than 15.kg pediatric donor kidneysP N Bretan, C Freise, R Goldstein, et al.
Kidney International|May 20, 2003
Health-related fitness and quality of life following steroid withdrawal in renal transplant recipientsPatricia L Painter, K S Topp, J B Krasnoff, et al.
Transplantation Proceedings|February 1, 1991
Improved results with combined donor-specific transfusion (DST) and sequential therapy protocolO Salvatierra, J McVicar, J Melzer, et al.
Transplantation Proceedings|February 1, 1987
Observations relating to the incidence of the acquired immune deficiency syndrome and other possibly associated conditions in a large population of renal transplant recipientsN J Feduska, H A Perkins, J Melzer, et al.
Transplantation|January 27, 1997
Immunologic and patient selection strategies for successful utilization of less than 15 kg pediatric donor kidneys--long term experiences with 40 transplantsP N Bretan, C Friese, R B Goldstein, et al.
Clinical Nephrology|August 31, 2006
Long-term administration of enteric-coated mycophenolate sodium (EC-MPS; myfortic) is safe in kidney transplant patientsM Salvadori, H Holzer, G Civati, et al.
Transplantation Proceedings|February 1, 1987
Donor-specific blood transfusions versus cyclosporine--the DST storyO Salvatierra, J Melzer, F Vincenti, et al.
Transplantation|May 27, 1994
Determination of blood flow to the transplanted kidney. A novel application of phase-contrast, cine magnetic resonance imagingB D Myers, F G Sommer, K Li, et al.
Transplantation|January 11, 2000
Prednisone withdrawal in kidney transplant recipients on cyclosporine and mycophenolate mofetil--a prospective randomized study. Steroid Withdrawal Study GroupN Ahsan, D Hricik, A Matas, et al.
Pageof 3